相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
Yanqiu Wang et al.
BMC CANCER (2019)
Safety and Tolerability of c-MET Inhibitors in Cancer
Alberto Puccini et al.
DRUG SAFETY (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
Henning Reis et al.
CLINICAL LUNG CANCER (2018)
Targeted therapy for metastatic colorectal cancer
Timothy J. Price et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
MET Amplification in Esophageal Squamous Carcinoma
Phillip D. Michaels et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma
Ken Hatogai et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
Conor A. Bradley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met
Guang-Zong Chen et al.
JOURNAL OF CANCER (2017)
A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma
Lipika Goyal et al.
CANCER (2017)
Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study
Jing Huang et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma
Haixing Wang et al.
TUMOR BIOLOGY (2016)
C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome
Ya-Ping Xu et al.
JOURNAL OF CANCER (2016)
c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target
Yohei Ozawa et al.
BMC CANCER (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
HER2-directed therapy: current treatment options for HER2-positive breast cancer
Shahid Ahmed et al.
BREAST CANCER (2015)
Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
Hyo Song Kim et al.
ONCOTARGET (2015)
Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma
W. Cao et al.
ONCOGENESIS (2015)
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
Katia Nones et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
Timothy Iveson et al.
LANCET ONCOLOGY (2014)
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song et al.
NATURE (2014)
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
Hiroaki Kato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Armando Santoro et al.
LANCET ONCOLOGY (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
Isabela Martins Gonzaga et al.
BMC CANCER (2012)
Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer
Yuji Toiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical Phenotypes
Hua Su et al.
CLINICAL CANCER RESEARCH (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion
Katharine D. Grugan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome
Udal S. Kammula et al.
CANCER LETTERS (2007)
Multiple management modalities in esophageal cancer: Epidemiology, presentation and progression, work-up, and surgical approaches
M Koshy et al.
ONCOLOGIST (2004)
Functional expression of HGF and its receptor in human colorectal cancer
JM Otte et al.
DIGESTION (2000)
Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas
WS Park et al.
APMIS (2000)
分享论文
